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a b s t r a c t
Human papillomaviruses (HPV) infect stratiﬁed epithelia and link their life cycles to epithelial
differentiation. The HPV E5 protein plays a role in the productive phase of the HPV life cycle but its
mechanism of action is still unclear. We identify a new binding partner of E5, A4, using a membrane-
associated yeast-two hybrid system. The A4 protein co-localizes with HPV 31 E5 in perinuclear regions
and forms complexes with E5 and Bap31. In normal keratinocytes, A4 is found primarily in basal cells
while in HPV positive cells high levels of A4 are seen in both undifferentiated and differentiated cells.
Reduction of A4 expression by shRNAs, enhanced HPV genome ampliﬁcation and increased cell
proliferation ability following differentiation but this was not seen in cells lacking E5. Our studies
suggest that the A4 protein is an important E5 binding partner that plays a role in regulating cell
proliferation ability upon differentiation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human papillomaviruses (HPVs) are small DNA viruses that infect
stratiﬁed epithelia at various body locations (Hebner and Laimins,
2006). Over 120 HPV types have been identiﬁed and nearly one-third
of these infect epithelia in the genital tract. Genital HPV viruses are
further subdivided into the high risk types (such as HPV-16,–18,
31) that are associated with cancer development, and low-risk
types (such as HPV-6, 11) which cause benign lesions (Lowy et al.,
1994; zur Hausen and de Villiers, 1994).
The HPV productive life cycle is coupled to the differentiation of the
host cell. Following entry, HPV genomes are established in the nucleus
at about 50–100 copies per cell that replicate in synchrony with
cellular chromosomes. When normal basal cells divide, one of the
daughter cells detaches from the basement membrane, stops prolifer-
ating and undergoes differentiation in suprabasal layers (Watt, 1998).
In contrast, in HPV infections, the daughter cell that migrates away
from the basement membrane remains active in the cell cycle as it
undergoes differentiation in suprabasal layers. HPV genomes are
replicated to high levels in highly differentiated cells in a process
called ampliﬁcation that depends on host cell replication “machinery”
(Dollard et al., 1992; Hummel et al., 1992; Frattini et al., 1996; Ruesch
and Laimins, 1998).
In the high-risk HPV types, three viral proteins have been
reported to promote oncogenic activities: E6, E7 and E5. The high-
risk E6 proteins are approximately 18 kDa in size, and are localized
to both the nuclear and cytoplasmic compartments. (Howie et al.,
2009). E6 interacts with a variety of cellular factors including the
tumor suppressor p53 in complex with the cellular ubiquitin ligase
E6AP leading to rapid degradation of p53 (Scheffner et al., 1990;
Werness et al., 1990). The E7 oncoprotein, which is similar in size
to E6, is localized primarily to the nucleus (McLaughlin-Drubin
and Munger, 2009) and targets the retinoblastoma (Rb) proteins
for degradation (Dyson et al., 1989). The combination of E6 and E7
can efﬁciently immortalize a variety cell types (Hawley-Nelson
et al., 1989; Munger et al., 1989).
While the transforming activities of high risk HPV E6 and E7 are
well characterized, the role of E5 in tumor progression remains
poorly understood. The high-risk E5 proteins are small hydrophobic
peptides of approximately 83 amino acids in size that localize to the
membranes of the endoplasmic reticulum (ER) and nuclear envelope
(Leechanachai et al., 1992; Conrad et al., 1993). E5 has been shown to
potentiate the immortalization activity of E6 and E7 in in vitro assays
(Bouvard et al., 1994; Valle and Banks, 1995; Stoppler et al., 1996).
Importantly, targeted expression of HPV16 E5 to the skin of trans-
genic mouse model rapidly induces cutaneous tumors (Maufort et al.,
2007). In estrogen treated E5 transgenic mice, E5 expression alone
was sufﬁcient to induce cervical tumors indicating that it can act as
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an oncogene (Maufort et al., 2010). In addition, E5 has been shown to
transform several rodent ﬁbroblast cell lines and this appears linked
to enhanced EGFR (epidermal growth factor receptor) activity in a
ligand-dependent manner (Straight et al., 1993). In keratinocytes
transfected with either wildtype or E5 mutant HPV 31 genomes, no
change in the levels of phosphorylated or total EGFR was seen
suggesting that E5 has additional targets in these cells. The HPV 16
E5 oncoprotein has also been shown to interact with the 16 kDa
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subunit of vacuolar ATPase proton pump, however, HPV E5 proteins
are localized to endoplasmic reticulum membranes and not endo-
somes suggesting this may not be signiﬁcant interaction in kerati-
nocytes (Straight et al., 1995; Disbrow et al., 2005). Recent studies
have shown that HPV 31 E5 interacts with Bap31 (B-cell-associated
protein 31) (Ladasky et al., 2006; Regan and Laimins, 2008),
a ubiquitously expressed 28-kDa membrane protein that is highly
enriched in the ER (Annaert et al., 1997; Ng et al., 1997). Importantly,
this interaction is important for regulation of differentiation-
dependent late viral functions (Regan and Laimins, 2008).
In this study we identify another binding partner of E5, the A4
protein. A4 is a small transmembrane lipoprotein of 152 amino
acids that was initially found in differentiated human colonic
epithelium (Oliva et al., 1993). This hydrophobic lipoprotein is
localized in the endoplasmic reticulum and A4 has been reported
to interact with Bap31 (Wang et al., 2003). HPV E5 enhances the
differentiation-dependent expression of A4 and this contributes to
regulating the proliferation ability of cells upon differentiation
which is necessary for the viral life cycle.
Results
A4 is a novel target of HPV E5 identiﬁed by yeast two-hybrid screen
To identify novel binding partners of HPV 31 E5, we used a
membrane-associated yeast two hybrid system (Regan and
Laimins, 2008) (DUAL membrane system) screen initially devel-
oped by Johnsson and Varshavsky (1994). In this system, the
C-terminal half of ubiquitin (Cub) is linked to the transcription
factor LexA-VP16 fused to a codon-modiﬁed HPV16 E5 protein. The
N-terminal half of ubiquitin (NubG) is fused to prey proteins from
HeLa cDNA library and a positive lac Z signal identiﬁes associations
that occur on cell membranes. Using a quantitative LacZ assay,
positive clones with the highest expression were isolated and A4, a
membrane protein localized to the ER, was identiﬁed as a
candidate for binding partner of E5.
A4 form complexes with HPV16 E5 and Bap31
Prior to screening if E5 and A4 formed complexes in human
cells, we ﬁrst investigated if A4 protein was expressed in a series of
cell lines using Western blot analysis. The A4 protein was found to
be expressed at high levels in Cos7, HFKs and HPV positive
keratinocytes such as LKPs and CIN 612 cells that maintain HPV
31 as stable episomes. In contrast, no A4 protein was found
expressed in 293TT cells that are derived from human embryonic
kidney cells (Fig. 1A).
Since A4 was identiﬁed as a potential binding partner of E5 by
yeast two hybrid analyses, we examined whether these two
proteins could form a complex in human cells. For this analysis,
293TT cells, which do not express A4, were transfected with
plasmids expressing A4 and AU1 tagged HPV16 E5 genes. At 48 h
posttransfection, cells were harvested and suspended in CHAPS
lysis buffer followed by immunoprecipitation with an antibody to
the AU1 tag. Precipitates were then analyzed by Western blot
analyses for A4 protein and showed that E5 protein forms a
complex with the human A4 protein (Fig. 1B). Our previous studies
identiﬁed the Bap31 protein as a binding partner of E5 (Regan and
Laimins, 2008), and it has also been reported that Bap31 can
associate with A4 (Wang et al., 2003) as both are localized to the
endoplasmic reticulum. We therefore investigated if E5 protein
could potentially bind both, A4 and Bap31. To address this
question, several transient transfections were performed in 293
TT cells using HPV16 E5, A4 and Bap31 expression vectors. Protein
lysates were prepared 48 h posttransfection as described above,
and tested by immunoprecipitation with an antibody to Bap31
following by Western blot analyses for A4, AU1 tag of E5 and
Bap31 proteins. Our data (Fig. 1C) demonstrate that E5 binds A4 in
the presence of endogenous and exogenous Bap31, indicating that
all three proteins can associate in complexes. Similar levels of A4
proteins are seen in 293 T cells transfected with A4 expression
vectors as are present in cells such as LKP or CIN 612 (Fig. 1D).
In our yeast two-hybrid assays, no endogenous Bap31 are
expressed yet we detected binding of A4 to E5. This indicates that
E5 can bind directly to A4 in the absence of Bap31. Finally, we
consistently observed an increase in A4 levels due to the presence
of E5 suggesting it may regulate levels of its expression (Fig. 1C).
A4 and HPV16 E5 co-localize to perinuclear regions consistent
with the endoplasmic reticulum
Having conﬁrmed that HPV E5 binds to the A4 protein, it was
important to determine whether these two proteins localize to the
same region inside the cell. The E5 protein has been shown to
localize to the perinuclear region consistent with the endoplasmic
reticulum and A4 has been reported to exhibit a similar perinuclear
localization pattern (Goldstein and Schlegel, 1990; Conrad et al.,
1993; Breitwieser et al., 1997; Disbrow et al., 2003; Wang et al.,
2003; Disbrow et al., 2005; Regan and Laimins, 2008). Since it was
possible that other viral proteins affected localization, HPV-31
positive CIN 612 cells were transiently co-transfected with vectors
expressing AU1-tagged HPV16 E5 and FLAG-tagged A4. At 48 h
post-transfection immunoﬂuorescence analyses were performed
and showed that E5 and A4 co-localized in the same perinuclear
regions (Fig. 1E). Similar perinuclear localization of E5 and A4 is
seen in 293TT cells transfected with expression vectors (Fig. 1F).
A4 expression is downregulated upon differentiation of HFKs
but is maintained at high levels in HPV positive cells
We next investigated whether expression of A4 protein
changes upon differentiation of normal human keratinocytes. For
this analysis, HFKs were differentiated in methylcellulose for 24 h
and 48 h as this allows for isolation of uniformly differentiated
populations of cells. Cell lysates were harvested and screened for
A4 levels by Western blot analyses. As shown in Fig. 2A, A4
Fig. 1. HPV E5 interacts with human A4 protein. (A) Expression of A4 protein in different cell types. In order to determine the expression of A4 proteins in different cell lines
the cell lysates from (A) 293TT and (B) Cos7 cells were prepared and analyzed by Western blot using antibodies against A4. Similar levels of A4 are seen in HPV positive cells.
(B) HPV16 E5 binds the human A4 protein. Total protein lysates were isolated from 293TT cells transfected with expression plasmids for HPV16 E5 and A4, and 1 mg of
protein lysate was immunoprecipitated with an AU1 tag E5 antibody. Precipitates were analyzed by Western blot using FLAG tag A4 antibody. (C) HPV16 E5 interacts with A4
and Bap31. 293TT cells were transiently co-transfected with pSG5 empty vector and DNA vectors expressing HPV16 E5, A4 and Bap31 genes. Cell lysates were
immunoprecipitated with an anti-Bap31 antibody and further analyzed by Western blotting using AU1, A4 and Bap31 antibodies. (D) Levels of A4 proteins are similar in
transfected and stable lines. Cell lysates from 293TT cells transfected with expression vector for A4 were compared to endogenous levels in LKP and CIN 612 cell lines by
Western blot analysis. (E) Colocalization of A4 and HPV16 E5. HPV31 positive keratinocytes (CIN612) were transiently co-transfected with FLAG-tagged A4 and AU1-tagged
HPV16 E5 expression vectors. Cells were immunostained with an anti-AU1 (FITC) and anti-FLAG (Texas Red) antibodies. Nuclei are visualized by staining with DAPI (blue).
Yellow signals in merged image represent co-localization of A4 and HPV16 E5 within the ER. Panels in middle show E5 alone and A4 alone localization in the absence of
transfection of the other vector. (F) Colocalization of A4 and transfected HPV16 E5. 293TT cells were transiently transfected with AU1-tagged HPV16 E5 and FLAG-tagged A4
expression vectors by themselves selves and in combination as indicated. Top panels show co-transfections while middle panels show A4 and E5 by themselves. Cells were
immunostained with an anti-FLAG and anti-AU1 (Texas Red) antibodies. Nuclei are visualized by staining with DAPI (blue). Yellow signals in merged image represent
co-localization of A4 and HPV16 E5 within the ER.
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proteins are expressed at high levels in undifferentiated normal
keratinocytes (HFKs) but expression decreases dramatically upon
differentiation. Similar effects were seen in HFKs isolated from
different donors (not shown). We next sought to investigate if A4
expression was altered in HPV positive keratinocytes. For these
studies, HFKs that stably maintain HPV31 genomes (LKP) were
differentiated in 1.5% methylcellulose for 24 h and 48 h. Western
blot analyses of whole cell lysates demonstrated high and constant
levels of A4 upon differentiation (Fig. 2B). Similar high levels of
expression following differentiation were seen in other human
epithelial cell lines that maintain HPV31 episomes generated
either by transfection (HFKg31) or derived from a cervical biopsy
of a CIN lesion (CIN612). After differentiation in semi-solid media
for 24 h and 48 h we again observed high expression of A4 protein
upon differentiation (Fig. 2C). The same expression pattern of A4
in normal and HPV31 positive keratinocytes was also observed in
cells differentiated in high calcium (data not shown).
To conﬁrm the activation of A4 expression in monolayer and
differentiated HPV positive cells, we grew organotypic raft cultures
and screened for expression by immunoﬂuoresence using an anti-
A4 antibody combined with an anti-Cytokeratin antibody (Fig. 2D
and E). These immunoﬂuoresence analyses conﬁrmed high level
expression of A4 protein in the basal layer but low expression in
the upper differentiated layers of the normal keratinocyte raft
cultures. In contrast, high levels of the A4 protein were observed
throughout all layers of HPV positive raft cultures. These data
conﬁrm our ﬁndings that HPV31 increases expression of A4
protein during epithelial differentiation.
HPV31 E5 oncoprotein may modulate A4 levels in human epithelium
Since HPV31 E5 forms complexes with the A4 protein, we
investigated if E5 was responsible for the increased levels of A4
Fig. 2. HPV increases the levels of A4 protein in HPV positive keratinocytes upon differentiation. (A–C) A4 expression in keratinocytes induced to differentiate by suspension
in methylcellulose for 24 and 48 h. (A) Normal human keratinocytes (HFK) (B) HPV 31 positive LKP cells and (C) biopsy derived HPV 31 positive CIN612. Cell lysates were
prepared and analyzed for protein expression byWestern Blot. Legend: MC: methylcellulose. Experiments shown in panels (A) and (B) were reproduced in three independent
experiments. (D and E) Immunostaining of organotypic raft cultures of normal (D) and LKP HPV 31 positive keratinocytes (E). Cell differentiation was induced by growing
keratinocytes in organotypic raft cultures for two weeks. Histological cross-sections were examined by immunohistochemistry using an antibody to A4 (FITC) and
Cytokeratin (Texas Red). Left panel: A4 staining; middle panel: K10 staining; right panel: merge. Nuclear staining is DAPI (40 ,6-diamidino-2-phenylindole).
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upon differentiation. Initially, we attempted to establish stable cell
lines overexpressing codon modiﬁed 16E5 or 31E5 from retroviral
vectors but in multiple experiments the cells failed to survive
selection, which contrasted with cells transfected with control
plasmids. This indicated that high-level expression of E5 could be
toxic in our cells. As an alternate approach to study the effect of E5
on A4 levels, we generated HFKs stably transfected with HPV31
genomes in which a translation termination stop codon had been
inserted into the E5 ORF (HPVg31 E5KO) and compared expression
to that seen in normal keratinocytes or cells with wild type
genomes. All sets of cells were examined for A4 expression by
Western blot analyses using cell lysates of undifferentiated and
differentiated keratinocytes. As shown in Fig. 3, the amount of A4
protein decreases upon differentiation in HPVg31E5KO cells,
similar to that seen in differentiated normal keratinocytes. We
have previously demonstrated that effects seen in keratinocytes
induced to differentiate in high-calcium media accurately recapi-
tulate differentiation seen in raft cultures (Moody and Laimins,
2009; Bodily et al., 2011; Gunasekharan and Laimins, 2013). We
conclude that E5 is necessary for enhanced levels of A4 upon
differentiation.
HPV31 E5 induces high A4 levels to support cell proliferative
ability upon differentiation
Our data indicate that E5 may control A4 levels upon differentia-
tion and it was previously shown that cells that maintained HPV31
genomes in which E5 was mutated exhibited decreased viral
ampliﬁcation as well as cell proliferation ability in differentiating
cells (Fehrmann et al., 2003). The knockdown of Bap31 knockdown
similarly inhibits cell proliferation ability upon differentiation of HPV
positive keratinocytes (Regan and Laimins, 2008), but has no effect
on HPV ampliﬁcation of stable replication. We therefore investigated
whether A4 as a binding partner of E5 had any effect on HPV
ampliﬁcation and proliferation ability. To examine the effect of
reducing A4 levels, we infected HPV 31 positive cells with lenti-
viruses expressing shRNAs against A4 (Fig. 4A) and screened for
HPV31 genome ampliﬁcation upon differentiation by Southern Blot.
Interestingly, cells in which A4 was knocked down (LKPshA4)
showed increased levels of viral episomes in undifferentiated cells
and these were maintained at high levels upon differentiation. The
level of HPV episomes in undifferentiated and differentiated cells in
which A4 was knocked down was increased over that seen in
undifferentiated wt cells and similar to that seen upon differentiation
(Fig. 4B). This suggests that knock down of A4 has a positive effect on
HPV replication. In contrast to stable knockdowns in HPV positive
cells, we were unable to obtain viable cells following knockdown of
A4 in normal keratinocytes.
It was next important to investigate if A4 knockdown had any
effect on cell proliferation of HPV positive keratinocytes following
differentiation. Wildtype and shA4 knockdown HPV 31 positive cell
lines were differentiated in 1.5% methylcellulose for 48 h and cells
were then re-plated to new dishes. After 5 days the number of cells
was determined and we consistently observed a signiﬁcant increase of
cell growth in the A4 knock down cells as compared to the wild type
HPV 31 positive cells (Fig. 4C and D). Since HPV31 genomes containing
mutated E5 exhibit decreased cell proliferation following differentia-
tion (Fehrmann and Klumpp et al., 2003) we wanted to test whether
A4 knockdown could restore this ability in cells containing mutant E5
proteins. For this analysis, we knocked down A4 with shRNAs in cells
that maintain HPV 31 genomes with mutated E5 (HFKg31E5KOshA4).
In these cells only partial (54%) A4 knockdown was achieved as
determined by Western blot assay (Fig. 4A). The same re-plating assay
described above was performed following cell differentiation in semi-
solid media and showed that knockdown of A4 did not restore cell
proliferation ability to that seen in wt cells (Fig. 4C, D). This suggests
that the effects of A4 on proliferative ability are signiﬁcant only in the
presence of a functional E5 protein.
Discussion
Our studies identify the proteolipid protein, A4, as a binding
partner of HPV 31 E5. The 17 kDa A4 protein has characteristics of
a four transmembrane ion channel (Breitwieser et al., 1997) and
co-localizes with E5 to the endoplasmic reticulum. A4 was identiﬁed
as a binding partner of HPV 16 E5 through the use of split-ubiquitin
membrane associated yeast two-hybrid screen (Johnsson and
Varshavsky, 1994; Regan and Laimins, 2008) and complex formation
was conﬁrmed in human cells through co-immunoprecipitation
studies. The A4 protein can also form complexes with another
endoplasmic reticulum protein, Bap31, that we previously reported
also bound to E5 (Regan and Laimins, 2008). Since yeast cells do not
contain a Bap31 homolog, this indicated the interaction of A4 with E5
maybe direct. In our studies we attempted to conﬁrm that the two
factors bound independently to E5 using human cell lines. All cells we
examined were found to express Bap31 and this is consistent with
previous reports (Quistgaard et al., 2013). While many cells express A4,
293TT embryonic kidney cells were found to be A4 deﬁcient. Using
these cells Bap31 binding to E5 was found to be independent of A4
binding. Since all human cells express Bap31, we tried to abrogate
BAP31 expression by use of shRNAs but were never able to reduce
amounts by more than 50% suggesting Bap31 may be an essential
protein. Future studies involving a detailed mutagenesis of E5 binding
sequences may help to determine if these factors bind the same
sequences or act through different binding sites on E5.
The A4 protein is normally expressed in a differentiation-
dependent manner. In primary keratinocytes, A4 expression is
restricted to undifferentiated basal cells and is absent from
differentiated suprabasal layers. This contrasts with Bap31 expres-
sion, which is expressed in both basal as well as suprabasal cells
and its expression is not changed by HPV proteins. Using organo-
typic rafts as well as methylcellulose induced differentiation, we
observed that A4 was uniformly expressed in both undifferen-
tiated and differentiated layers of cells that maintain HPV epi-
somes. The E5 protein is responsible for inducing expression in
suprabasal layers. At present we are unsure if this effect is
mediated at the level of transcription or through post-
transcriptional effects. In epithelial cancers that lack the ability
to differentiate yet retain stratiﬁcation ability, A4 is also found in
suprabasal cells suggesting that A4 expression is linked to pro-
liferative ability of cells (Oliva et al., 1993; Breitwieser et al., 1997).
Upon differentiation of cells that maintain HPV viral DNA as
episomes, genome ampliﬁcation is induced in suprabasal layers.
This process requires differentiating cells to remain active in the
cell cycle as host replication proteins such as polymerases and
PCNA are needed for viral replication (Bodily and Laimins, 2011).
Fig. 3. HPV31 E5 viral oncoprotein modulates expression of A4 protein in differ-
entiated keratinocytes. A4 levels are increased by HPV E5 oncoproteins in human
keratinocytes upon differentiation. The protein levels of A4 protein were analyzed by
Western blot methods using the following cell lines: wild type human foreskin cells
(HFKs), HFKs infected with HPV31 (HFKg31) and HFKs infected with E5 knockout
HPV31 genomes (HFKg31E5KO). All sets of cells were differentiated in high calcium
and harvested for detection of A4 protein levels using an antibody to A4.
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HPV genome ampliﬁcation occurs as cells transit through S phase
into G2/M. This ability to retain proliferative capability upon differ-
entiation is mediated by both E7 and E5 proteins (Fehrmann et al.,
2003; Regan and Laimins, 2008; Banerjee et al., 2011). Our studies
demonstrate that A4 expression in suprabasal cells is important to
regulate this proliferative capability in differentiating cells. In con-
trast to studies with Bap31, knockdown of A4 enhanced proliferative
ability rather than decreased it. Our studies suggest that A4 can
modulate proliferative capacity and that is dependent on the pre-
sence of a functional E5 protein. A4 has been shown to associate with
PI3K resulting in activation of Akt phosphorylation, which is impor-
tant for cell proliferation and future studies will determine if this is
the critical target of A4 action. Our studies indicate that the action of
A4 is central to regulating this activity, however, it appears to act in
Fig. 4. HPV31 replication and cell proliferation are enhanced in A4 shRNA knock down keratinocytes. (A) Western blot analyses of A4 stable knock down in keratinocytes.
HPV31 positive keratinocytes LKP were infected with lentiviral particles carrying shRNAs against the A4 gene. Infected cells were selected with puromycin for two weeks.
ImageJ program was used to quantify knockdown of A4 in cell line LKPshA4. (B) Southern blot analysis of LKP and LKPshA4 keratinocytes. Total genomic DNA was harvested
from monolayer and differentiated cultures and digested with DpnI to remove residual input DNA and XbaI to linearize the HPV31 genomes. The Southern blot was
hybridized with a probe that contains the complete HPV31 genome. (C, D): Cell proliferation assay. LKP, LKPshA4, HFKg31E5KO and HFKg31E5KOshA4 cell lines were
differentiated by suspension culture in methylcellulose. 48 h later cells were re-plated into new dishes and cultured for few days. Colonies were visible under microscope on
day 5 (C). The total cell number was estimated on day 5 using TC10 automated cell counter (BioRad) (D). Data are means7standard deviations (error bars), n¼3.
nnnnPo0.0001 indicates values signiﬁcantly different from the control (LKP).
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an opposite manner to Bap31. We also observed that knockdown of
A4 lead to an increase in genome copy number in undifferentiated
cells and that this enhanced level was maintained throughout
differentiation. A4 may thus be important for helping to restrict
high level viral replication to differentiated suprabasal cells. Our
studies indicate that the interactions of both A4 and Bap31 are
critical to E5 functions.
A4 and Bap31 are both co-localized to the endoplasmic reticulum
together with E5 proteins. Previous studies had suggested that E5
could form a complex with the subunits of the vacuolar ATPAse
(V-ATPase); however, the V-ATPAse is localized to late endosomes and
not the endoplasmic reticulum indicating it is likely not a physiological
target of E5 (Suprynowicz et al., 2010). Interestingly, A4 shares an
amino acid sequence similarity with the V-ATPAse in the ﬁrst
transmembrane region that could be a potential interacting domain
with E5 and explain why previous studies implicated V-ATPase as a
binding partner of E5. Future mutational analyses of A4 should
elucidate if this is the E5 interacting region (Breitwieser et al., 1997).
In summary, our studies demonstrate that high risk HPV E5
proteins bind A4 and maintain high levels of A4 during differentiation.
The binding of A4 as well as interactions of Bap31 are necessary to
regulate proliferation ability of HPV positive cells upon differentiation.
Further analyses of A4 and Bap31 functions will help to provide critical
new insights in the role of the E5 in HPV pathogenesis.
Materials and methods
Cell culture
Human foreskin keratinocytes (HFKs) were derived from neo-
natal human foreskin epithelia as described in Wilson and Laimins
(2005) and were maintained in serum-free keratinocytes growth
medium supplemented with bovine pituitary extract, insulin,
hydrocortisone and epidermal growth factor (Lonza, Walkersville,
MD). Stable cell lines expressing HPV E6 and E7 were generated by
transduction of retroviral vectors and selected in G418 (Sigma) as
previously described (Melar-New and Laimins, 2010).
To create cell lines containing HPV31 genomes (HFKg31) and E5
knockout HPV31 genomes (HFKg31E5KO), HFKs were transfected
with HPV type 31 genomes and genomes of HPV type 31 lacking
the E5 gene followed by selection with antibiotics as described
previously (Wilson and Laimins, 2005).
CIN 612 cells are derived from a biopsy and maintain HPV 31
episomes while LKP cells are derived from normal human foreskin
keratinocytes transfected with HPV 31 DNA and maintain episomes
(Frattini and Lim et al., 1996) HFKs, all stably transfected HFK cell
lines along with LKP and CIN612 cell lines that maintain HPV 31
episomes were grown in the presence of 3T3 J2 ﬁbroblast feeders
treated with mitomycin C and cultured in E medium supplemented
with mouse epidermal growth factor (EGF) (5 ng/mL (Frattini et al.,
1996); BD Biosciences, San Jose, CA) as described (Fehrmann and
Laimins, 2005).
293TT, Cos7 and HaCat cells were grown in DMEM medium
supplemented with 10% fetal bovine serum (Life Technologies,
Grand Island, NY). For transient transfection assays, 293TT cells
were transfected using ployethylenimine reagent at a ﬁnal con-
centration of 0.2 mg/mL (Polyscience, Inc., Warrington, PA) at 30%
conﬂuence. Cells were harvested 48 h postransfection for further
analyses.
Differentiation of keratinocytes
To induce differentiation in high calcium LKP, CIN612 and HPV
31 stably transfected HFKs were cultured in the absence of 3T3 J2
feeders in EGF free E medium for 24 h prior to differentiation.
After 24 h cells were switched to EGF free E medium containing
CaCl2 at a ﬁnal concentration 1.5 mM for 48 h, 72 h and/or 96 h.
Alternatively, keratinocytes were differentiated in semisolid media
as described in (Melar-New and Laimins, 2010).
Western blot analyses
Total cell protein extracts were prepared with RIPA lysis buffer
containing a cocktail of protease inhibitors (Roche, Branchburg, NJ)
and quantitated using the NanoDrop ND2000 Spectrophotometer
(Thermo Fisher, Suwanee, GA). Protein samples were electrophor-
esed on 15% sodium dodecyl sulfate-polyacrilamide (SDS) gels and
subsequently transferred to polyvinylidene diﬂuoride membranes
(EMD Milipore, Darmstadt, Germany). The membrane was then
blocked in a 5% nonfat milk solution (0.1% Tween 2 in PBS),
followed by incubation with primary antibodies: anti-A4, anti-Flag
(Sigma-Aldrich, St. Louis, MO), anti-AU1 (Covance, Madison, WI),
anti-GAPDH (Santa Cruz, Dallas, TX), anti-Involucrin (Santa Cruz),
anti-Cytokeratin (Santa Cruz) and anti-Bap31 (AbCam,, Cambridge,
MA). Proteins were visualized via enhanced chemiluminescence
(GE, Healthcare, Waukesha, WI).
Immunoprecipitation analyses
Cell lysates of transiently transfected 293TT cells expressing
various proteins (A4 and/or E5 and/or Bap31) were prepared with
CHAPS (15 mM 3-[(3-cholamidopropyl) dimethylammonio]-1-pro-
panesulfonate) buffer solution (CHAPS, 30 mM NaCl, 1 mM EDTA,
50 mM Tris–HCl [pH7.4]) (Sigma-Aldrich) 48 h posttransfection as
described in Regan and Laimins (2008). Antibodies used in the
analyses include: anti-AU1 (Covance) and anti-Bap31 (AbCam).
Immunoﬂuorescence
The expression pattern of A4 proteins were examined by immuno-
ﬂuorescence of cross sections of raft tissue. Paraformaldehyde-ﬁxed,
parafﬁn-embedded tissue on silanized slides were heated at 50 1C for
30 min, washed in Xylenes, 100% and 95% Ethanol and ﬁnally in PBS.
The slides were then incubated in 10 mM Citrate Solution (pH 6.0) at
95 1C for 30 min, followed by an additional 20 min incubation at room
temperature. Subsequently slides were washed with PBS and blocked
in Normal Goat Serum (Life Technologies) and 1% Triton X-100 in
humid chamber. Incubationwith primary antibodies was performed at
room temperature for 2 h. Slides were then washed with PBS solution
containing 1% triton and incubated with secondary Alexa-Fluor
antibodies in light protected humid chamber for 30 min. After staining
with DAPI, sections were mounted and analyzed under inverted
ﬂuorescent microscope.
Yeast two-hybrid screen
To detect possible protein interactions with E5 protein a yeast
two-hybrid screen that is based on the split-ubiquitin technique
was performed as described (Johnsson and Varshavsky, 1994;
Regan and Laimins, 2008).
Plasmids
To construct A4 expression plasmids, the A4 open reading
frame isolated from the yeast two-hybrid positive clones was
PCR ampliﬁed and cloned into the pSG5. The Bap31 and HPV31
E5 expression vectors were previously described (Regan and
Laimins, 2008). A codon optimized HPV16 E5n with an AU1 tag
was a generous gift from R. Schlegel and was subcloned in a pSG5
vector (Disbrow and Sunitha et al., 2003).
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Southern blot
Stable A4 knockdown cell line expressing shRNA against A4
were established as described (Mighty and Laimins, 2011). Cells
were differentiated in high calcium as described above and total
DNA was isolated from harvested cells using DNeasy Blood &
Tissue Kit (Qiagen Hilden, Germany). Ten micrograms of each total
DNA sample was digested with DpnI and XhoI and electrophor-
esed in a 0.8% agarose gel overnight and transferred to Gene
Screen nylon membranes (Bio-Rad, Des Plaines, IL) using vacuum
transfer according to the manufacturer's protocols. The DNA
HPV31 probe was labeled with [32P]dCTP using Ready-To-Go
DNA-labeling beads (Amersham Biosciences, Buckinghamshire,
England) and column puriﬁed. The membrane was hybridized
with labeled probe in hybridization solution overnight, washed
and visualized by autoradiography.
Proliferation test
HPV positive cells were grown in the presence of mitomycin
C-treated J2 3T3 ﬁbroblasts. At the approximately 80% conﬂuence,
feeder cells were removed, keratinocytes were harvested and
number of cells was determined by TC10 automated cell counter
(BioRad). Two and a half of millions of cells were resuspended in
1.5% methylcellulose for 48 h to induce differentiation. The kera-
tinocytes were then collected, washed with PBS, and replated as
monolayer cultures into new dishes. The total number of cells was
determined after 5 days in culture by TC10 automated cell counter.
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